Studies Linking GLP-1 Medications to NAION Several peer-reviewed studies have confirmed an increased risk of NAION in patients taking GLP-1 drugs: Harvard Medical School & Mass General Brigham Study (JAMA Ophthalmology, 2024) 9% of diabetic patients taking semaglutide developed NAION, compared to 1.8% on other diabetes drugs (a 4-fold increased risk)
This eliminates the need for intrusive, irritable needles, which generate medical waste, pose a danger of infection, and need to be administered by a medical expert [215]
Maggie Cloninger, president and co-founder of Hope for Feral Hearts, says there are still more questions than answers
Your digestive system gradually adjusts to the slower gastric emptying rate, and bacterial fermentation normalizes as you establish eating patterns that work withrather than againstyour new metabolic state
D.KamiyaA.et al (2022)
Available from: Seok WP, Goodpaster BH, Jung SL, Kuller LH, Boudreau R, De Rekeneire N, et al